-
Infographic – Health Care A.I. Funds Jump in Q1
Venture funding for start-ups providing artificial intelligence services in health care climbed to a record high volume in the first quarter of 2021.
-
Medical Devices to Reduce Military Travel Disorders
Biomedical engineers at university labs are designing medical devices that reduce jet lag and intestinal problems faced by military service members.
-
New Biotech Creating Precision Cancer Therapies
A biotechnology company began work in public to develop new treatments that target proteins responsible for gene expression, beginning with cancer.
-
Early-Stage Life Science Investment Fund Raises $515M
A new venture investment fund raised $515 million for life science start-ups, and its business incubator partner added five biotechs to its seed round portfolio.
-
Synthetic Bio Company Goes Public in $2.5B Merger
A company developing synthetic biology and engineering tools for biotechnology is becoming a public company through a special-purpose acquisition.
-
MD Anderson, Broad Institute Partner on Rare Cancers
MD Anderson Cancer Center and the Broad Institute are developing a new research platform for better understanding rare types of cancer.
-
New Biotech Developing Synthetic Long-Term RNA
A new enterprise, created by a life science venture capital company, began work on developing therapies with long-acting synthetic RNA.
-
Infographic – Public Money Funds Covid-19 Vaccines
As the race to produce and distribute Covid-19 vaccines intensifies, financing of this global public health project is starting to emerge.
-
Biotechs Partner on Gene-Edited Cancer Cell Therapies
Two biotechnology companies are collaborating on using the gene editing technique Crispr to create engineered immune-system cells to treat cancer.
-
AI Gene Therapy Platform Gains $100M in Early Funds
A company using machine learning to create engineered viruses to deliver gene therapies is raising $100 million in its first venture funding round.